Select Medical Holdings Corporation (SEM)

NYSE: SEM · Real-Time Price · USD
16.44
+0.03 (0.18%)
May 1, 2026, 4:00 PM EDT - Market closed
Market Cap2.04B -3.2%
Revenue (ttm)5.52B +5.8%
Net Income130.13M -23.2%
EPS1.07 -21.8%
Shares Out 124.02M
PE Ratio15.32
Forward PE12.59
Dividend$0.25 (1.52%)
Ex-Dividend DateMay 14, 2026
Volume1,658,249
Open16.45
Previous Close16.41
Day's Range16.42 - 16.46
52-Week Range11.65 - 18.53
Beta0.80
AnalystsBuy
Price Target15.17 (-7.73%)
Earnings DateApr 30, 2026

About SEM

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. The Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. The Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including reha... [Read more]

Sector Healthcare
IPO Date Sep 25, 2009
Employees 45,300
Stock Exchange NYSE
Ticker Symbol SEM
Full Company Profile

Financial Performance

In 2025, Select Medical Holdings's revenue was $5.45 billion, an increase of 5.12% compared to the previous year's $5.19 billion. Earnings were $142.87 million, a decrease of -32.52%.

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for SEM stock is "Buy." The 12-month stock price target is $15.17, which is a decrease of -7.73% from the latest price.

Price Target
$15.17
(-7.73% downside)
Analyst Consensus: Buy
Stock Forecasts

News

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches in the Select Medical Take-Private Transaction

SAN DIEGO, May 01, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, PLLP has launched an investigation into whether the board members of Select Medical Holdings Corporation (NYSE: ...

2 days ago - GlobeNewsWire

Select Medical Holdings Earnings Call Transcript: Q1 2026

Q1 2026 saw 5% revenue growth but a 6.5% decline in adjusted EBITDA, with EPS at $0.36 adjusted for transaction costs. The take-private deal is progressing, and guidance for 2026 is unchanged. Segment growth was led by inpatient rehab, while critical illness margins were pressured by Medicare Advantage denials.

2 days ago - Transcripts

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2026 and Cash Dividend

MECHANICSBURG, Pa., April 30, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31...

3 days ago - PRNewsWire

Select Medical Holdings Corporation Announces Expiration of Hart-Scott-Rodino Waiting Period

MECHANICSBURG, Pa., April 28, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) announced today that the waiting period under the Hart-Scott...

5 days ago - PRNewsWire

Kaskela Law Seeks Additional Compensation for Select Medical Holdings Shareholders and Encourages Investors to Contact the Firm to Learn How to Participate

Is the buyout price of $16.50 too low? PHILADELPHIA, April 16, 2026 /PRNewswire/ -- Kaskela Law LLC is investigating the fairness of the recently announced proposed buyout of Select Medical Holdings C...

17 days ago - PRNewsWire

Select Medical Holdings Corporation to Announce First Quarter 2026 Results on Thursday, April 30, 2026

MECHANICSBURG, Pa., April 9, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2026 on T...

24 days ago - PRNewsWire

SEM Shareholder Buyout Investigation Launched by Kaskela Law: Does $16.50 Per Share Buyout Proposal Shortchange Select Medical Shareholders?

Kaskela Law is investigating the fairness of the $16.50 per share Select Medical Holdings Corp. (“Select Medical”) (NYSE: SEM) shareholder buyout.

5 weeks ago - GlobeNewsWire

SHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Select Medical Holdings Corporation (NYSE - SEM)

BALA CYNWYD, Pa., March 03, 2026 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Select Medical Holdings Corpora...

2 months ago - GlobeNewsWire

Select Medical Holdings Corporation to be Acquired by Consortium Led by Robert A. Ortenzio, Martin F.

MECHANICSBURG, Pa., March 2, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that it has entered into a definitive agreeme...

2 months ago - PRNewsWire

Select Medical Holdings Earnings Call Transcript: Q4 2025

Q4 revenue grew over 6% year-over-year, but Adjusted EBITDA declined 10% due to higher health insurance costs. Inpatient rehab led growth, while outpatient margins fell on payer mix and discounts. 2026 guidance projects revenue of $5.6B–$5.8B and margin improvement in outpatient.

2 months ago - Transcripts

Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2025, Its 2026 Business Outlook, and Cash Dividend

MECHANICSBURG, Pa., Feb. 19, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended...

2 months ago - PRNewsWire

PHILADELPHIA EAGLES RENEW DEAL WITH SELECT MEDICAL NAMING NOVACARE REHABILITATION THE TEAM'S OFFICIAL PHYSICAL THERAPY PARTNER

MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and the Philadelphia Eagles have announced a multi-year extension of its longstanding 25-year partnershi...

2 months ago - PRNewsWire

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results and Business Outlook on Thursday, February 19, 2026

MECHANICSBURG, Pa., Feb. 17, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended Dece...

2 months ago - PRNewsWire

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2025 Results on Thursday, February 19, 2026

MECHANICSBURG, Pa., Jan. 21, 2026 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended Dece...

3 months ago - PRNewsWire

Select Medical Holdings Corporation Acknowledges Executive Chairman's Take-Private Proposal

MECHANICSBURG, Pa. , Nov. 24, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) has received a non-binding indication of interest from Rober...

5 months ago - PRNewsWire

Select Medical Holdings Earnings Call Transcript: Q3 2025

Revenue and adjusted EBITDA grew over 7% year-over-year, driven by strong inpatient and critical illness recovery segments, while outpatient rehab faced margin pressure from Medicare cuts and payer mix. CMS's delay of the 20% transmittal rule provided a $12–$15 million EBITDA benefit.

6 months ago - Transcripts

Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2025 and Cash Dividend

MECHANICSBURG, Pa. , Oct. 30, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended Septembe...

6 months ago - PRNewsWire

Select Medical Holdings Corporation to Announce Third Quarter 2025 Results on Thursday, October 30, 2025

MECHANICSBURG, Pa. , Oct. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2025 ...

7 months ago - PRNewsWire

SELECT MEDICAL HOLDINGS CORPORATION APPOINTS THOMAS P. MULLIN AS CHIEF EXECUTIVE OFFICER AND ANNOUNCES OTHER CHANGES INVOLVING LONG-TENURED LEADERS

MECHANICSBURG, Pa. , Sept. 2, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) today announced the appointment of Thomas P.

8 months ago - PRNewsWire

Select Medical Holdings Earnings Call Transcript: Q2 2025

Revenue grew nearly 5% to $1.3B, with adjusted EBITDA up and EPS rising 88% year-over-year. Inpatient rehab outperformed, while critical illness recovery faced regulatory headwinds. Guidance for 2025 is reaffirmed, with strong growth and capital allocation plans.

9 months ago - Transcripts

Select Medical Holdings Corporation Announces Results For Its Second Quarter Ended June 30, 2025 and Cash Dividend

MECHANICSBURG, Pa. , July 31, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its second quarter ended June 30...

9 months ago - PRNewsWire

Select Medical Holdings Corporation to Announce Second Quarter 2025 Results on Thursday, July 31, 2025

MECHANICSBURG, Pa. , June 27, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2025 on ...

11 months ago - PRNewsWire

SELECT MEDICAL SIGNS AGREEMENT WITH BALLAD HEALTH TO OPERATE JOINT VENTURE CRITICAL ILLNESS RECOVERY HOSPITAL

MECHANICSBURG, Pa. , June 27, 2025 /PRNewswire/ -- Select Medical Corporation today announced it signed a membership interest purchase agreement with Ballad Health to jointly operate Select Specialty ...

11 months ago - PRNewsWire

The Best Health Care Stocks to Buy

The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Other symbols: BDXCI
1 year ago - Kiplinger

Select Medical Holdings Earnings Call Transcript: Q1 2025

Inpatient rehab delivered strong growth, offsetting challenges in outpatient and critical illness recovery due to regulatory and weather impacts. Revenue rose 2% year-over-year, but adjusted EBITDA fell 9%. 2025 guidance was slightly adjusted, with robust development plans and ongoing advocacy on regulatory issues.

1 year ago - Transcripts